Financial health

Cardiol Therapeutics Inc. Class A Financial health

Financial health for Cardiol Therapeutics Inc. Class A (CRDL) on 6ix covers company data, market context, news, risks, and AI research briefs.

websiteCRDLFinancial health/analysis/CRDL/financial-health

Cardiol Therapeutics Inc. Class A

Cardiol Therapeutics Inc. Class A investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to CRDL.

Stock profile

Ticker

CRDL

Asset type

Stock

Market cap

$122.3M

Sector

Health Technology

Industry

Biotechnology

Currency

CAD

Ticker listings

Cardiol Therapeutics Inc. Class A may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • CRDL primary listing
  • A2PA9E
  • CT9

Research sections

Valuation

Review valuation context for Cardiol Therapeutics Inc. Class A.

Future growth

Review future growth context for Cardiol Therapeutics Inc. Class A.

Past performance

Review past performance context for Cardiol Therapeutics Inc. Class A.

Financial health

Review financial health context for Cardiol Therapeutics Inc. Class A.

Dividend

Review dividend context for Cardiol Therapeutics Inc. Class A.

Management

Review management context for Cardiol Therapeutics Inc. Class A.

Ownership

Review ownership context for Cardiol Therapeutics Inc. Class A.

Other information

Review other information context for Cardiol Therapeutics Inc. Class A.

Community

Review community context for Cardiol Therapeutics Inc. Class A.